120 related articles for article (PubMed ID: 36641651)
1. Down-regulation of SLC16A-AS1 and LINC00900 lncRNAs in Iranian patients with breast cancer.
Dorostgoo Z; Fattahi AS; Moosavi SS; Ghafouri-Fard S; Oskooei VK
Breast Dis; 2022; 41(1):521-528. PubMed ID: 36641651
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of autophagy-related long non-coding RNAs in Iranian patients with breast cancer.
Safarzadeh A; Akhavan-Bahabadi M; Hussen BM; Nicknam A; Eslami S; Pouresmaeili F; Ghafouri-Fard S; Taheri M
Pathol Res Pract; 2022 Nov; 239():154146. PubMed ID: 36195025
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of vimentin and the related lncRNA network in breast cancer.
Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061
[TBL] [Abstract][Full Text] [Related]
4. DICER-AS1 lncRNA: A putative culprit in the pathogenesis of gastric cancer.
Afrough H; Ghafouri-Fard S; Yousefi H; Pakzad P; Kholghi Oskooei V; Taheri M
Exp Mol Pathol; 2020 Oct; 116():104490. PubMed ID: 32663487
[TBL] [Abstract][Full Text] [Related]
5. Identification of expression of CCND1-related lncRNAs in breast cancer.
Hussen BM; Hidayat HJ; Ghafouri-Fard S
Pathol Res Pract; 2022 Aug; 236():154009. PubMed ID: 35803208
[TBL] [Abstract][Full Text] [Related]
6. Expression Analysis of Long Non-Coding RNAs Related With FOXM1, GATA3, FOXA1 and ESR1 in Breast Tissues.
Hassani B; Taheri M; Asgari Y; Zekri A; Sattari A; Ghafouri-Fard S; Pouresmaeili F
Front Oncol; 2021; 11():671418. PubMed ID: 34094972
[TBL] [Abstract][Full Text] [Related]
7. Opposite trends of GAS6 and GAS6-AS expressions in breast cancer tissues.
Lavasani A; Hussen BM; Taheri F; Sattari A; Yousefi H; Omrani MD; Nazer N; Ghafouri-Fard S; Taheri M
Exp Mol Pathol; 2021 Feb; 118():104600. PubMed ID: 33359886
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker.
Torkashvand S; Basi A; Ajdarkosh H; Rakhshani N; Nafisi N; Mowla SJ; Moghadas A; Mohammadipour M; Karbalaie Niya MH
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2897-2902. PubMed ID: 34582659
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis of Rho GTPase-related lncRNAs in breast cancer.
Nicknam A; Khojasteh Pour S; Hashemnejad MA; Hussen BM; Safarzadeh A; Eslami S; Taheri M; Ghafouri-Fard S; Jamali E
Pathol Res Pract; 2023 Apr; 244():154429. PubMed ID: 36996609
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer.
Dashti S; Ghafouri-Fard S; Esfandi F; Oskooei VK; Arsang-Jang S; Taheri M
Exp Mol Pathol; 2020 Feb; 112():104359. PubMed ID: 31837323
[TBL] [Abstract][Full Text] [Related]
11. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer.
Mehrpour Layeghi S; Arabpour M; Shakoori A; Naghizadeh MM; Mansoori Y; Tavakkoly Bazzaz J; Esmaeili R
J Transl Med; 2021 Aug; 19(1):364. PubMed ID: 34446052
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of PPAR-related lncRNAs in breast cancer.
Ghafouri-Fard S; Nicknam A; Safarzadeh A; Eslami S; Samsami M; Jamali E
Pathol Res Pract; 2023 Nov; 251():154844. PubMed ID: 37820438
[TBL] [Abstract][Full Text] [Related]
14. In silico identification of MAPK14-related lncRNAs and assessment of their expression in breast cancer samples.
Dashti S; Taherian-Esfahani Z; Kholghi-Oskooei V; Noroozi R; Arsang-Jang S; Ghafouri-Fard S; Taheri M
Sci Rep; 2020 May; 10(1):8316. PubMed ID: 32433496
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA and LncRNA Expression Profiles in Human Estrogen Receptor Positive Breast Cancer.
Shao X; Huang P; Shi L; Lei L; Cao W; Chen Z; Wang X; Zheng Y
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775882
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of a panel of immune-related lncRNAs in breast cancer.
Ghafouri-Fard S; Asadi M; Sohrabi B; Arsang-Jang S; Mehravaran E; Taheri M; Samsami M
Pathol Res Pract; 2021 Aug; 224():153534. PubMed ID: 34175685
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of AFAP1-AS1 and AFAP1 in breast cancer.
Dianatpour A; Faramarzi S; Geranpayeh L; Mirfakhraie R; Motevaseli E; Ghafouri-Fard S
Cancer Biomark; 2018; 22(1):49-54. PubMed ID: 29439313
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of MAPKAPK5-AS1, PXN-AS1 and URB1-AS1 lncRNAs in non-functioning pituitary adenoma.
Taheri M; Safarzadeh A; Bahranian A; Eslami S; Dilmaghani NA; Ghafouri-Fard S; Sharifi G
J Cell Mol Med; 2023 Jun; 27(11):1550-1556. PubMed ID: 37154079
[TBL] [Abstract][Full Text] [Related]
20. Expression assessment of a panel of long non-coding RNAs in gastric malignancy.
Esfandi F; Salehnezhad T; Taheri M; Afsharpad M; Hafez AA; Oskooei VK; Ghafouri-Fard S
Exp Mol Pathol; 2020 Apr; 113():104383. PubMed ID: 31982396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
